Editorial: The Immunobiology of HLA-Haploidentical Hematopoietic Cell Transplantation

Editorial: The Immunobiology of HLA-Haploidentical Hematopoietic Cell Transplantation

Bibliographic Details
Main Authors:	Antonella Mancusi, Christopher G. Kanakry, Antonio Pierini
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-05-01
Series:	Frontiers in Immunology
Subjects:	haploidentical transplantation T-cell depleted grafts T-cell-replete grafts post-transplantation cyclophosphamide immune reconstitution adoptive cell therapy
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2020.01031/full

Similar Items

Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-versus-Host Disease Prophylaxis
by: Maria Queralt Salas, et al.
Published: (2019-06-01)

The Evolution of T Cell Depleted Haploidentical Transplantation
by: Franco Aversa, et al.
Published: (2019-11-01)

Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
by: Razan Mohty, et al.
Published: (2024-12-01)

Influence of ABO compatibility on haploidentical hematopoietic stem-cell transplant
by: Rajesh B Sawant, et al.
Published: (2023-01-01)

Haploidentical stem cell transplant: Established treatment, expanding horizons
by: Mukul Aggarwal, et al.
Published: (2016-01-01)

Current status of conditioning regimens in haploidentical hematopoietic cell transplantation
by: Junichi Sugita, et al.
Published: (2024-12-01)

Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for Sézary Syndrome
by: Madoka Kanda-Kato, et al.
Published: (2020-09-01)

T‐cell replete haploidentical stem cell transplantation with low dose anti‐thymocyte globulin for relapsed/refractory Ewing sarcoma family tumors
by: Hideki Sano, et al.
Published: (2022-07-01)

T-Cell Depleted Haploidentical Transplantation in Children With Hematological Malignancies: A Comparison Between CD3+/CD19+ and TCRαβ+/CD19+ Depletion Platforms
by: Marta Gonzalez-Vicent, et al.
Published: (2022-06-01)

Adoptive T Cell Therapy Following Haploidentical Hematopoietic Stem Cell Transplantation
by: Ping Zhang, et al.
Published: (2019-08-01)

Haploidentical hematopoietic stem cell transplantation in a myelofibrosis patient with primary graft failure
by: Cristina Tecchio, et al.
Published: (2018-01-01)

Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report
by: Naoki Okada, et al.
Published: (2023-08-01)

Antithymocyte Globulin Plus Post-Transplant Cyclophosphamide Combination as an Effective Strategy for Graft-versus-Host Disease Prevention in Haploidentical Peripheral Blood Stem Cell Transplantation for Children with High-Risk Malignancies
by: Kang-Hsi Wu, et al.
Published: (2022-11-01)

Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding
by: Natalia S. Nunes, et al.
Published: (2019-11-01)

CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation
by: Antonella Mancusi, et al.
Published: (2019-12-01)

Delayed kidney transplantation after HLA-haploidentical hematopoietic cell transplantation in a young woman with myelodysplastic syndrome with renal failure
by: Kevin C. Miller, et al.
Published: (2022-01-01)

Real‐world experience: Introduction of T cell replete haploidentical transplantations in a single center
by: Gwendolyn vanGorkom, et al.
Published: (2021-08-01)

Haploidentical Stem Cell Transplantation in Children With Hematological Malignancies Using αβ+ T-Cell Receptor and CD19+ Cell Depleted Grafts: High CD56dim/CD56bright NK Cell Ratio Early Following Transplantation Is Associated With Lower Relapse Incidence and Better Outcome
by: Miguel A. Diaz, et al.
Published: (2019-10-01)

T-Cell-Replete Versus ex vivo T-Cell-Depleted Haploidentical Haematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukaemia and Other Haematological Malignancies
by: Katharina Kleinschmidt, et al.
Published: (2021-12-01)

Intensified conditioning regimen with fludarabine combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in children with high-risk acute leukemia
by: Junjie Cao, et al.
Published: (2023-12-01)

CMV Infection and CMV-Specific Immune Reconstitution Following Haploidentical Stem Cell Transplantation: An Update
by: Xiao-Hua Luo, et al.
Published: (2021-10-01)

Effects of anti-HLA donor-specific antibodies and desensitization on engraftment of haploidentical hematopoietic stem cell transplantation
by: MA Yao, et al.
Published: (2024-02-01)

Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT
by: Jaime Sanz, et al.
Published: (2020-05-01)

Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients
by: Yu Wang, et al.
Published: (2019-09-01)

Repeated haploidentical allogeneic hematopoietic stem cell transplantation with TCR αβ/CD19 depletion in patient with primary myelofibrosis. Case report
by: Elmira I. Kolgaeva, et al.
Published: (2021-07-01)

Can doses of post-transplantation cyclophosphamide in haploidentical stem cell allografts be reduced?
by: Juan Carlos Olivares-Gazca, et al.
Published: (2023-12-01)

Low-dose ATG combined with low-dose PTCY in preventing GVHD after haploidentical transplantation: a retrospective analysis of 90 cases
by: LEI Jinmei, et al.
Published: (2024-02-01)

Impact of graft-versus-host disease prophylaxis on immune reconstitution in patients after allogeneic hematopoietic stem cell transplantation
by: E. D. Mikhaltsova, et al.
Published: (2021-11-01)

Immune Reconstitution after Haploidentical Donor and Umbilical Cord Blood Allogeneic Hematopoietic Cell Transplantation
by: Hany Elmariah, et al.
Published: (2021-01-01)

Human Leukocyte Antigen–Haploidentical Haematopoietic Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for Paediatric Haematological Malignancies
by: Takuro Nishikawa
Published: (2024-01-01)

Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation
by: Paula Muñiz, et al.
Published: (2022-09-01)

Commentary: Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4+ T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell Transplantation
by: Jessica Stokes, et al.
Published: (2022-04-01)

Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT
by: Jaime Sanz, et al.
Published: (2021-05-01)

Elafin as a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide
by: Laura Solán, et al.
Published: (2021-02-01)

Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation
by: Ying Yang, et al.
Published: (2022-09-01)

Sirolimus versus cyclosporine in haploidentical stem cell transplantation with posttransplant cyclophosphamide and mycophenolate mofetil as graft‐versus‐host disease prophylaxis
by: Rafael Hernani, et al.
Published: (2021-05-01)

Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies
by: Elisa Zaghi, et al.
Published: (2019-11-01)

Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective study
by: Xingying Li, et al.
Published: (2023-10-01)

Persistence of KIRneg NK cells after haploidentical hematopoietic stem cell transplantation protects from human cytomegalovirus infection/reactivation
by: Clara Di Vito, et al.
Published: (2024-01-01)

Haploidentical donor stem cell transplantation had a lower incidence of bronchiolitis obliterans syndrome compared with HLA-matched sibling donor transplantation in patients with hematologic malignancies: Benefit from ATG?
by: Guangyang Weng, et al.
Published: (2022-10-01)